LeonaBio, Inc.: Spruce Street Capital LP discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Spruce Street Capital LP disclosed a stake of more than 5% in LeonaBio, Inc. via a Schedule 13G filing with the SEC (accession 0000902664-26-004525). The 13G designation signals a passive position rather than an activist campaign, though the filing did not specify the exact share count or percentage held. The disclosure puts Spruce Street among LeonaBio's significant institutional holders and may draw attention from investors tracking ownership concentration in the stock. What to watch next: any amendment to the Schedule 13G, which would reveal changes in the size of the position, and whether other institutions follow with similar disclosures.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Spruce Street Capital LP, LeonaBio, Inc.